ANXA2 and endometrial carcinoma: The rate of positive expression of ANXA2 in endometrial carcinoma, atypical hyperplasia, and normal endometrium tissues was 95.2 % (80/84), 83.3 % (25/30), and 55.6 % (10/18), respectively (Table 1).